Previous close | 35.94 |
Open | 35.70 |
Bid | 36.01 x 0 |
Ask | 36.02 x 0 |
Day's range | 35.62 - 36.04 |
52-week range | 23.69 - 36.51 |
Volume | |
Avg. volume | 6,688,473 |
Market cap | 65.256B |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | 15.58 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.60 (4.40%) |
Ex-dividend date | 21 May 2024 |
1y target est | N/A |
Manulife Financial Corporation ("Manulife") today announced the applicable dividend rates for its Non-cumulative Rate Reset Class 1 Shares Series 15 (the "Series 15 Preferred Shares") (TSX: MFC.PR.L) and Non-cumulative Floating Rate Class 1 Shares Series 16 (the "Series 16 Preferred Shares").
John Hancock, along with its Toronto-based parent company Manulife (NYSE: MFC), today announced a five-year, multimillion-dollar research collaboration with the Massachusetts Institute of Technology (MIT) AgeLab, a multi-disciplinary research institute that works with business, government, and NGOs, leading innovation and research to help improve the quality of life for the aging population and their loved ones. Over the next five years, Manulife/John Hancock and the MIT AgeLab will collaborate
Manulife Financial Corporation (Manulife) announced today that each of the following 13 nominees proposed to be elected at the Annual Meeting of Shareholders held earlier today has been elected. The detailed results of the vote for the election of directors are set out below.